Table 3.

EuroQol 5-Dimension 5-Level.

Group (n)	Baseline	Early Follow-Up		Late Follow-Up
	Mean ± SD	Mean ± SD	p-Value vs. Baseline	Mean ± SD	p-Value vs. Baseline
Type of response
CR (29)	0.66 ± 0.28	0.72 ± 0.19	0.2398	0.66 ± 0.29	0.9107
PR (17)	0.59 ± 0.47	0.65 ± 0.44	0.5698	0.54 ± 0.45	0.4787
STD + PD (9)	0.66 ± 0.31	0.48 ± 0.51	0.5778	0.41 ± 0.53	0.3925
Type of anatomical site of the lesion(s)
A (11)	0.62 ± 0.42	0.76 ± 0.18	0.4315	0.60 ± 0.35	0.3131
M (34)	0.64 ± 0.28	0.68 ± 0.30	0.8223	0.61 ± 0.34	0.4138
P (10)	0.47 ± 0.59	0.46 ± 0.56	0.1490	0.48 ± 0.58	0.0788
Number of lesion(s)
Single (34)	0.60 ± 0.38	0.62 ± 0.40	0.6509	0.54 ± 0.42	0.3992
Multiple (21)	0.63 ± 0.37	0.72 ± 0.24	0.3572	0.66 ± 0.33	0.8301
Size of lesion(s)
≤30 mm (37)	0.72 ± 0.20	0.76 ± 0.24	0.6743	0.67 ± 0.33	0.1916
>30 mm (18)	0.37 ± 0.54	0.41 ± 0.44	0.5154	0.38 ± 0.45	0.6699
Whole study population
55	0.59 ± 0.38	0.64 ± 0.37	0.4269	0.57 ± 0.40	0.4279

A, anterior; CR, complete response; M, intermediate; P, posterior; PD, progressive disease; PR, partial response; STD, stable disease.